Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing

This document is a response-to-comments notice regarding MolDX: Melanoma Risk Stratification Molecular Testing (LCD DL38018) and the notice for L37725, summarizing that comments were received during the stated comment/notice periods. It does not contain clinical coverage criteria, indications, limitations, documentation requirements, or frequency limits; for specific coverage rules refer to LCD DL38018 and L37725.